Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

NCT: NCT06321575 · RECRUITING

NCT IDNCT06321575
StatusRECRUITING
Start Date2024-06-20
Completion2026-11
SponsorAvantec Vascular (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to establish reasonable assurance of safety and effectiveness of the Golazo® Peripheral Atherectomy System when used as indicated in 159 subjects with symptomatic infrainguinal peripheral arterial disease (PAD) in up to 20 investigational sites in the U.S.

Frequently Asked Questions

What is The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)?

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial) is a clinical trial registered under NCT06321575. Current status: RECRUITING.

What is the status of NCT06321575?

The current status of NCT06321575 (The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)) is: RECRUITING.

When did The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial) start?

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial) started on 2024-06-20.

Related Devices

K170987Captus Vascular Retrieval SystemAvantec Vascular Corporation K251207Sangria™ Thrombectomy SystemAvantec Vascular Corporation K180416ViperWire Advance Guide Wire, Stealth 360 Orbital Peripheral Atherectomy Device (PAD), DIAMONDBACK 360 Peripheral Atherectomy SystemCardiovascular Systems, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑